CPT1A and posterior cortical atrophy: Earlier, we reported that the CPT1A inhibitor etomoxir reduced androgen receptor expression (full length and variant form), while CPT1A knockdown increased the sensitivity of PCa cells to androgen and sensitized the cells to anti-androgen therapy [17,18,21].